These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 35554644)

  • 21. Prognostic Value of Pulmonary Transit Time by Cardiac Magnetic Resonance on Mortality and Heart Failure Hospitalization in Patients With Advanced Heart Failure and Reduced Ejection Fraction.
    Houard L; Amzulescu MS; Colin G; Langet H; Militaru S; Rousseau MF; Ahn SA; Vanoverschelde JJ; Pouleur AC; Gerber BL
    Circ Cardiovasc Imaging; 2021 Jan; 14(1):e011680. PubMed ID: 33438438
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incremental value of extracellular volume assessment by cardiovascular magnetic resonance imaging in risk stratifying patients with suspected myocarditis.
    Gräni C; Bière L; Eichhorn C; Kaneko K; Agarwal V; Aghayev A; Steigner M; Blankstein R; Jerosch-Herold M; Kwong RY
    Int J Cardiovasc Imaging; 2019 Jun; 35(6):1067-1078. PubMed ID: 30756221
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of Myocardial Tissue Characterization Using Native T1 to Predict the Occurrence of Adverse Events in Patients With Chronic Kidney Disease and Severe Aortic Stenosis.
    Ramchand J; Iskandar JP; Layoun H; Puri R; Chetrit M; Burrell LM; Krishnaswamy A; Griffin BP; Yun JJ; Flamm SD; Kapadia SR; Kwon DH; Harb SC
    Am J Cardiol; 2022 Nov; 183():85-92. PubMed ID: 36031412
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic Implications of Global Longitudinal Strain by Feature-Tracking Cardiac Magnetic Resonance in ST-Elevation Myocardial Infarction.
    Reindl M; Tiller C; Holzknecht M; Lechner I; Beck A; Plappert D; Gorzala M; Pamminger M; Mayr A; Klug G; Bauer A; Metzler B; Reinstadler SJ
    Circ Cardiovasc Imaging; 2019 Nov; 12(11):e009404. PubMed ID: 31679391
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic Value of Hepatic Native T1 and Extracellular Volume Fraction in Patients with Pulmonary Arterial Hypertension.
    Guo J; Wang L; Wang J; Wan K; Gong C; Chen X; Guo J; Xu Y; He J; Yin L; Pu S; Wen B; Chen C; Han Y; Chen Y
    J Am Heart Assoc; 2022 Nov; 11(22):e026254. PubMed ID: 36346060
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel and simple cardiac magnetic resonance score (PE
    Isaak A; Bratz J; Kravchenko D; Mesropyan N; Eckardt I; Bischoff LM; Weinhold L; Kuetting D; Pieper CC; Attenberger U; Zimmer S; Luetkens JA
    Eur Radiol; 2023 Aug; 33(8):5498-5508. PubMed ID: 36949253
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Myocardial tissue characterization by cardiac magnetic resonance imaging using T1 mapping predicts ventricular arrhythmia in ischemic and non-ischemic cardiomyopathy patients with implantable cardioverter-defibrillators.
    Chen Z; Sohal M; Voigt T; Sammut E; Tobon-Gomez C; Child N; Jackson T; Shetty A; Bostock J; Cooklin M; O'Neill M; Wright M; Murgatroyd F; Gill J; Carr-White G; Chiribiri A; Schaeffter T; Razavi R; Rinaldi CA
    Heart Rhythm; 2015 Apr; 12(4):792-801. PubMed ID: 25533585
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The reliability and feasibility of non-contrast adenosine stress cardiovascular magnetic resonance T1 mapping in patients on haemodialysis.
    Poli FE; Gulsin GS; March DS; Abdelaty AM; Parke KS; Wormleighton JV; McCann GP; Burton JO; Graham-Brown MP
    J Cardiovasc Magn Reson; 2020 Jun; 22(1):43. PubMed ID: 32507107
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic value of mid-term cardiovascular magnetic resonance follow-up in patients with non-ischemic dilated cardiomyopathy: a prospective cohort study.
    Xu Y; Li Y; Wang S; Wan K; Tan Y; Li W; Wang J; Guo J; Ghaithan S; Cheng W; Sun J; Zhang Q; Han Y; Chen Y
    J Cardiovasc Magn Reson; 2024 Summer; 26(1):101002. PubMed ID: 38237899
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differences in native T1 and native T2 mapping between patients on hemodialysis and control subjects.
    Graham-Brown MPM; Gulsin GS; Poli F; Parke K; Burton JO; McCann GP
    Eur J Radiol; 2021 Jul; 140():109748. PubMed ID: 33962255
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Features of cardiovascular magnetic resonance native T1 mapping in maintenance hemodialysis patients and their related factors.
    Zhang C; Yao L; Liu M; Zhou Y
    Ren Fail; 2024 Dec; 46(1):2310078. PubMed ID: 38293793
    [TBL] [Abstract][Full Text] [Related]  

  • 32. T1-Mapping and Outcome in Nonischemic Cardiomyopathy: All-Cause Mortality and Heart Failure.
    Puntmann VO; Carr-White G; Jabbour A; Yu CY; Gebker R; Kelle S; Hinojar R; Doltra A; Varma N; Child N; Rogers T; Suna G; Arroyo Ucar E; Goodman B; Khan S; Dabir D; Herrmann E; Zeiher AM; Nagel E;
    JACC Cardiovasc Imaging; 2016 Jan; 9(1):40-50. PubMed ID: 26762873
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Myocardial T1 and T2 Mapping by Magnetic Resonance in Patients With Immune Checkpoint Inhibitor-Associated Myocarditis.
    Thavendiranathan P; Zhang L; Zafar A; Drobni ZD; Mahmood SS; Cabral M; Awadalla M; Nohria A; Zlotoff DA; Thuny F; Heinzerling LM; Barac A; Sullivan RJ; Chen CL; Gupta D; Kirchberger MC; Hartmann SE; Weinsaft JW; Gilman HK; Rizvi MA; Kovacina B; Michel C; Sahni G; González-Mansilla A; Calles A; Fernández-Avilés F; Mahmoudi M; Reynolds KL; Ganatra S; Gavira JJ; González NS; García de Yébenes Castro M; Kwong RY; Jerosch-Herold M; Coelho-Filho OR; Afilalo J; Zataraín-Nicolás E; Baksi AJ; Wintersperger BJ; Calvillo-Arguelles O; Ederhy S; Yang EH; Lyon AR; Fradley MG; Neilan TG
    J Am Coll Cardiol; 2021 Mar; 77(12):1503-1516. PubMed ID: 33766256
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Combined Incremental Prognostic Value of LVEF, Late Gadolinium Enhancement, and Global Circumferential Strain Assessed by CMR.
    Mordi I; Bezerra H; Carrick D; Tzemos N
    JACC Cardiovasc Imaging; 2015 May; 8(5):540-549. PubMed ID: 25890580
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patients with end-stage renal disease requiring hemodialysis benefit from percutaneous coronary intervention after non-ST-segment elevation myocardial infarction.
    Fu Y; Sun H; Zuo K; Guo Z; Xu L; Chen M; Wang L
    Intern Emerg Med; 2022 Jun; 17(4):1087-1095. PubMed ID: 35018545
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pathophysiology of LV Remodeling in Survivors of STEMI: Inflammation, Remote Myocardium, and Prognosis.
    Carrick D; Haig C; Rauhalammi S; Ahmed N; Mordi I; McEntegart M; Petrie MC; Eteiba H; Lindsay M; Watkins S; Hood S; Davie A; Mahrous A; Sattar N; Welsh P; Tzemos N; Radjenovic A; Ford I; Oldroyd KG; Berry C
    JACC Cardiovasc Imaging; 2015 Jul; 8(7):779-89. PubMed ID: 26093923
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic Value of Adenosine Stress Perfusion Cardiac Magnetic Resonance Imaging in Older Adults with Known or Suspected Coronary Artery Disease.
    Kaolawanich Y; Boonyasirinant T
    Arq Bras Cardiol; 2022 Jul; 119(1):97-106. PubMed ID: 35830106
    [TBL] [Abstract][Full Text] [Related]  

  • 38. T1 mapping and cardiac magnetic resonance feature tracking in mitral valve prolapse.
    Guglielmo M; Fusini L; Muscogiuri G; Baessato F; Loffreno A; Cavaliere A; Rizzon G; Baggiano A; Rabbat MG; Muratori M; Tamborini G; Danza LML; Del Torto A; Tonet E; Viani G; Mushtaq S; Conte E; Bonalumi G; Gripari P; Zanobini M; Andreini D; Alamanni F; Pepi M; Guaricci AI; Pontone G
    Eur Radiol; 2021 Feb; 31(2):1100-1109. PubMed ID: 32803414
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-Term Prognostic Value of Stress CMR in Patients With Heart Failure and Preserved Ejection Fraction.
    Pezel T; Hovasse T; Sanguineti F; Kinnel M; Garot P; Champagne S; Toupin S; Unterseeh T; Garot J
    JACC Cardiovasc Imaging; 2021 Dec; 14(12):2319-2333. PubMed ID: 34419409
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic value of cardiac markers in ESRD: Chronic Hemodialysis and New Cardiac Markers Evaluation (CHANCE) study.
    Iliou MC; Fumeron C; Benoit MO; Tuppin P; Calonge VM; Moatti N; Buisson C; Jacquot C
    Am J Kidney Dis; 2003 Sep; 42(3):513-23. PubMed ID: 12955679
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.